Literature DB >> 24035524

Contrast-enhanced multiphasic CT and MRI findings of adenosquamous carcinoma of the pancreas.

Yuqin Ding1, Jianjun Zhou, Huihong Sun, Deming He, Mengsu Zeng, Shengxiang Rao.   

Abstract

OBJECTIVE: The objective was to retrospectively study computed tomography (CT) and magnetic resonance imaging (MRI) findings of adenosquamous carcinoma of the pancreas (PASC).
MATERIALS AND METHODS: Twelve patients (six women and six men; mean age, 61.3 years; range, 47-78 years) who presented with PASC as documented by pathologic examination underwent CT (n=10) or both CT and MRI (n=2) examination. Two radiologists evaluated the images and determined the location, size, margin, internal attenuation or signal intensity, contrast enhancement, and pattern for each tumor. Additionally, the presence of poorly enhanced areas, upstream main pancreatic duct (MPD) dilatation, pancreatic atrophy, and peripancreatic tissue metastasis were evaluated. Images were cross-referenced to surgical and pathologic findings.
RESULTS: Masses were distributed throughout the pancreas (head, n=6; body, n=1; and tail, n=5). The tumor size ranged from 2.4 to 5.5 cm with an average size of 3.7 cm. Eight (66.7%) masses were ill defined, and seven (58.3%) were partially exophytic. Twelve (100%) masses showed heterogeneous and poorly enhanced areas. The lesions showed weak (n=5), moderate (n=5), or intense (n=2) progressive enhancement. The diameter of MPD in six patients ranged from 3.0 to 5.0 mm with an average of 3.7 mm. Pancreatic atrophy was not found. In 10 patients (83.3%), masses invaded the peripancreatic tissues. Two patients had metastatic liver disease at presentation.
CONCLUSION: PASC typically presented as an ill-defined, hypovascular mass with a poorly enhanced area, exophytic tendency, and peripancreatic tissue invasion. Lack of pancreatic atrophy and mild MPD dilatation were also distinct from common duct pancreatic adenocarcinoma.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenosquamous carcinoma; Magnetic resonance imaging; Pancreas; X-ray computed tomography

Mesh:

Substances:

Year:  2013        PMID: 24035524     DOI: 10.1016/j.clinimag.2013.08.002

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  7 in total

1.  Extradomain-B Fibronectin-Targeted Dextran-Based Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Probe for Detecting Pancreatic Cancer.

Authors:  Zheng Han; Shuixing Zhang; Kenji Fujiwara; Jia Zhang; Yuguo Li; Jing Liu; Peter C M van Zijl; Zheng-Rong Lu; Lei Zheng; Guanshu Liu
Journal:  Bioconjug Chem       Date:  2019-04-15       Impact factor: 4.774

2.  Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma.

Authors:  Shuai Ren; Rui Zhao; Wenjing Cui; Wenli Qiu; Kai Guo; Yingying Cao; Shaofeng Duan; Zhongqiu Wang; Rong Chen
Journal:  Front Oncol       Date:  2020-08-25       Impact factor: 6.244

3.  Can lymphovascular invasion be predicted by contrast-enhanced CT imaging features in patients with esophageal squamous cell carcinoma? A preliminary retrospective study.

Authors:  Yang Li; Haiyan Su; Li Yang; Meng Yue; Mingbo Wang; Xiaolong Gu; Lijuan Dai; Xiangming Wang; Xiaohua Su; Andu Zhang; Jialiang Ren; Gaofeng Shi
Journal:  BMC Med Imaging       Date:  2022-05-17       Impact factor: 2.795

Review 4.  Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review.

Authors:  Erkut Borazanci; Sherri Z Millis; Ron Korn; Haiyong Han; Clifford J Whatcott; Zoran Gatalica; Michael T Barrett; Derek Cridebring; Daniel D Von Hoff
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

5.  Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer.

Authors:  Yusheng Shi; Xinjing Wang; Weize Wu; Junjie Xie; Jiabin Jin; Chenghong Peng; Xiaxing Deng; Hao Chen; Baiyong Shen
Journal:  Front Oncol       Date:  2021-01-15       Impact factor: 6.244

6.  Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions.

Authors:  Yan Deng; Bing Ming; Ting Zhou; Jia-Long Wu; Yong Chen; Pei Liu; Ju Zhang; Shi-Yong Zhang; Tian-Wu Chen; Xiao-Ming Zhang
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

7.  Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier.

Authors:  Fernando Martínez de Juan; María Reolid Escribano; Carmen Martínez Lapiedra; Fernanda Maia de Alcantara; María Caballero Soto; Ana Calatrava Fons; Isidro Machado
Journal:  World J Gastrointest Oncol       Date:  2017-09-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.